safrole has been researched along with fura-2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT; Chen, IS; Chen, JS; Chen, WC; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Lin, HC; Liu, SI; Lu, YC | 1 |
| Cheng, JS; Chou, CT; Fang, YC; Ho, CM; Hung, TY; Jan, CR; Kuo, CC; Kuo, DH; Li, YD; Liang, WZ; Lin, JR; Shieh, P; Sun, TK | 1 |
2 other study(ies) available for safrole and fura-2
| Article | Year |
|---|---|
Safrole-induced cellular Ca2+ increases and death in human osteosarcoma cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Carcinogens; Cell Death; Cell Line, Tumor; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Endoplasmic Reticulum; Fluorescent Dyes; Fura-2; Humans; Osteosarcoma; Phorbol Esters; Protein Kinase C; Safrole; Spectrometry, Fluorescence; Thapsigargin; Time Factors | 2006 |
The Mechanism of Safrole-Induced [Ca²⁺]i Rises and Non-Ca²⁺-Triggered Cell Death in SCM1 Human Gastric Cancer Cells.
Topics: Apoptosis; Calcium; Cell Death; Cell Line, Tumor; Fura-2; Humans; Safrole; Stomach; Type C Phospholipases | 2015 |